Aligos Therapeutics (ALGS) Asset Utilization Ratio (2021 - 2025)
Aligos Therapeutics (ALGS) has disclosed Asset Utilization Ratio for 5 consecutive years, with 0.02 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Asset Utilization Ratio rose 294.82% year-over-year to 0.02, compared with a TTM value of 0.02 through Dec 2025, up 294.82%, and an annual FY2025 reading of 0.03, up 814.4% over the prior year.
- Asset Utilization Ratio was 0.02 for Q4 2025 at Aligos Therapeutics, up from 0.01 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.24 in Q3 2023 and bottomed at 0.01 in Q4 2024.
- Average Asset Utilization Ratio over 5 years is 0.07, with a median of 0.06 recorded in 2024.
- The sharpest move saw Asset Utilization Ratio soared 793.29% in 2022, then tumbled 114.77% in 2025.
- Year by year, Asset Utilization Ratio stood at 0.02 in 2021, then skyrocketed by 793.29% to 0.16 in 2022, then tumbled by 30.71% to 0.11 in 2023, then crashed by 110.45% to 0.01 in 2024, then surged by 294.82% to 0.02 in 2025.
- Business Quant data shows Asset Utilization Ratio for ALGS at 0.02 in Q4 2025, 0.01 in Q3 2025, and 0.01 in Q2 2025.